Axenfeld-Rieger综合征的手术结局:一项多中心回顾性分析
该多中心回顾性研究纳入泰国和美国3家三级医院18岁前诊断为Axenfeld-Rieger综合征(ARS)的连续患者96例(189眼),评估青光眼发生的危险因素及首次青光眼手术的效果。平均随访7.5年期间57.3%发生青光眼,出生时诊断和心脏异常是危险因素;所有携带FOXC1致病变异者均发生青光眼。3年生存分析中无术式完全成功率超过25%,青光眼引流装置(GDD)的合格成功率(72.9%)显著高于小梁切开术(37.8%)或小梁切除术(27.8%)(P = .013)。
要点
- ARS患者平均随访7.5年期间57.3%发生青光眼,出生时诊断(aOR 6.45)和心脏异常(aOR 10.73)是危险因素。
- 所有携带FOXC1致病变异者均发生青光眼;70%的青光眼患者需手术,中位手术年龄6个月。
- 3年生存分析中无术式完全成功率超过25%;GDD合格成功率72.9%,显著高于小梁切开术37.8%和小梁切除术27.8%(P = .013)。
核心结论
- 超过半数ARS患者发生青光眼,出生时诊断ARS和存在心脏异常是主要危险因素。
- 尽管手术完全成功率仍低,GDD显示最高的合格成功率,可能是首选初次手术。
研究设计与样本
- 回顾性比较干预性病例系列,纳入泰国和美国3家三级医院2004年至2023年18岁前诊断为ARS伴或不伴青光眼的连续患者。
主要发现
- 共纳入96例患者(189眼),97%为双眼病变,50%为男性;超过三分之一病例进行了基因检测,其中半数鉴定出致病基因变异。
- 平均随访7.5年期间57.3%发生青光眼;出生时诊断的调整比值比(aOR)为6.45(95%CI 1.61-25.91),心脏异常的aOR为10.73(95%CI 1.20-95.55)。
- 所有携带FOXC1致病变异的患者均发生青光眼;70%的青光眼患者需手术,中位手术年龄为6个月。
- 3年生存分析时,无任何术式完全成功率超过25%;GDD的合格成功率为72.9%,显著高于小梁切开术的37.8%或小梁切除术的27.8%(P = .013)。
关键数值与推荐
- 完全成功定义为眼压(IOP)>5且≤21 mmHg,较基线降低≥20%,不使用青光眼药物、无再次手术或视力丧失;合格成功为相同IOP标准但使用药物。
- GDD合格成功率72.9% vs 小梁切开术37.8% vs 小梁切除术27.8%(P = .013)。
- 出生时诊断aOR 6.45(95%CI 1.61-25.91);心脏异常aOR 10.73(95%CI 1.20-95.55)。
临床怎么用
- 作者认为GDD显示最高的合格成功率,可能是首选初次手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify risk factors for glaucoma development and evaluate the effectiveness of primary glaucoma surgery in Axenfeld-Rieger syndrome (ARS)-associated glaucoma. DESIGN: Retrospective comparative interventional case series. SUBJECTS: Consecutive patients diagnosed with ARS with and without glaucoma before the age of 18 years at 3 tertiary hospitals in Thailand and the United States (2004-2023) were included. METHODS: Surgical outcomes were defined as: complete success-intraocular pressure (IOP) >5 and ≤21 mmHg with ≥20% reduction from baseline, without glaucoma medication, re-operation, or vision loss; qualified success-same IOP criteria but with medication use. MAIN OUTCOME MEASURES: Proportion of nonglaucomatous patients/eyes that developed glaucoma, complete and qualified surgical success, and genotyping results. RESULTS: Ninety-six patients (189 eyes) were included; 97% had bilateral disease, and 50% were male. Genetic testing was performed in over one-third of cases, with a causative gene variant identified in half. During a mean follow-up of 7.5 years, 57.3% developed glaucoma. Risk factors included diagnosis at birth (adjusted odds ratio [aOR] 6.45, 95% confidence interval [CI] 1.61-25.91) and cardiac anomalies (aOR 10.73, 95% CI 1.20-95.55). All patients with a causative FOXC1 variant developed glaucoma. Among those affected, 70% required surgery, typically at a median age of 6 months. At 3-year mark of survival analysis, no procedure achieved >25% complete success. Glaucoma drainage devices had significantly higher qualified success (72.9%) compared to goniotomy (37.8%) or trabeculotomy (27.8%) (P = .013). CONCLUSIONS: Over half of ARS patients developed glaucoma, with ARS diagnosed at birth, and the presence of cardiac anomalies as major risk factors. While complete surgical success remains low, GDD shows the highest qualified success and may be the preferred primary procedure.
引用
- Seresirikachorn K, Thiamthat W, Bitrian E, et al. Surgical Outcomes in Axenfeld-Rieger Syndrome: A Multicenter Retrospective Analysis. Am J Ophthalmol. 2025. PMID: 41151624. doi:10.1016/j.ajo.2025.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。